Both Ultrasound Features and Nuclear Atypia are Associated with Malignancy in Thyroid Nodules with Atypia of Undetermined Significance
- 18 Downloads
The optimal management of thyroid nodules that undergo fine-needle aspiration (FNA) with findings of atypia of undetermined significance (AUS) is unclear. Categorizing nodules by AUS subtype and ultrasound characteristics may improve risk stratification. Therefore, the purpose of this study is to evaluate the association between AUS subtype and ultrasound features on risk of malignancy (ROM).
We performed a review of all patients with a thyroid nodule who underwent an FNA at our institution between January 2010 and November 2015. Patients with AUS were divided into groups with (1) nuclear atypia, (2) architectural atypia, or (3) Hurthle cell atypia. Their ultrasound features were assessed using the American Thyroid Association (ATA) thyroid nodule sonographic patterns. We conducted a univariate and multivariable analysis to determine the association between AUS subtype and other variables of interest with ROM.
Of the 3428 thyroid nodules that underwent FNA, 237 (6.9%) had AUS. Of the 97 surgically resected nodules, 67 (69%) were benign and 30 (31%) were malignant. On univariate analysis nuclear atypia (p < 0.01) was associated with a thyroid malignancy. On multivariable analysis, both ATA high-risk ultrasound features (p = 0.04, odds ratio [OR] 3.68) and nuclear atypia (p < 0.01, OR 11.8) were independently associated with a final diagnosis of thyroid carcinoma.
Nuclear atypia and ATA high-risk ultrasound features are useful in identifying patients with AUS that are at a higher risk of thyroid malignancy. Surgeons should take these factors into consideration when evaluating patients with AUS.
The authors thank Dr. Alison Semrad and Dr. Kent Ishihara for their help reviewing and providing critical feedback on this manuscript. We would also like to thank Dr. Sandra Taylor for statistical assistance.
Department funds were used for incidental expenses.
The authors have no conflicts of interest to disclose.
- 2.Haugen BR, Alexander EK, Bible KC, et al. 2015 American Thyroid Association Management Guidelines for adult patients with thyroid nodules and differentiated thyroid cancer: The American Thyroid Association Guidelines Task Force on Thyroid Nodules and Differentiated Thyroid Cancer. Thyroid. 2016;26(1):1–133.CrossRefPubMedGoogle Scholar
- 5.National Comprehensive Cancer Network. Thyroid Carcinoma (Version 2.2017) https://www.nccn.org/professionals/physician_gls/pdf/thyroid_blocks.pdf. Accessed 23 Feb 2018.
- 7.Kim SJ, Roh J, Baek JH, et al. Risk of malignancy according to sub-classification of the atypia of undetermined significance or follicular lesion of undetermined significance (AUS/FLUS) category in the Bethesda system for reporting thyroid cytopathology. Cytopathology. 2017;28(1):65–73.CrossRefGoogle Scholar
- 10.Lee JH, Han K, Kim EK, et al. Risk stratification of thyroid nodules with atypia of undetermined significance/follicular lesion of undetermined significance (AUS/FLUS) cytology using ultrasonography patterns defined by the 2015 ATA Guidelines. Ann Otol Rhinol Laryngol. 2017;126(9):625–33.CrossRefGoogle Scholar
- 25.Park CS, Kim SH, Jung SL, et al. Observer variability in the sonographic evaluation of thyroid nodules. J Clin Ultrasound. 2010;38(6):287–93.Google Scholar
- 27.Gan TR, Nga ME, Lum JH, et al. Thyroid cytology-nuclear versus architectural atypia within the “Atypia of undetermined significance/follicular lesion of undetermined significance” Bethesda category have significantly different rates of malignancy. Cancer Cytopathol. 2017;125(4):245–56.CrossRefGoogle Scholar
- 28.Nikiforov, et al. Nomenclature revision for encapsulated follicular variant of papillary thyroid carcinoma. A paradigm shift to reduce overtreatment of indolent tumors. JAMA Oncol. https://doi.org/10.1001/jamaoncol.2016.0386. Published online April 14, 2016. Corrected on May 12, 2016.CrossRefPubMedGoogle Scholar